Assignee
AC IMMUNE SA
CH·36 granted patents·53 pending applications·194 citations·filing 2004–2025
Top patents by PatentIndex Score
89 records- 0197US7892544B2Humanized anti-beta-amyloid antibodyAC IMMUNE SA·Filed 2007·Granted Feb 22, 2011·55 cites·26 claims
- 0296US7772375B2Monoclonal antibodies that recognize epitopes of amyloid-betaAC IMMUNE SA·Filed 2006·Granted Aug 10, 2010·51 cites·15 claims
- 0394US9585956B2Polynucleotides encoding anti-amyloid beta monoclonal antibodiesAC IMMUNE SA·Filed 2015·Granted Mar 7, 2017·8 cites·21 claims
- 0493US9175094B2Monoclonal antibodyAC IMMUNE SA·Filed 2013·Granted Nov 3, 2015·9 cites·36 claims
- 0592US10711058B2Anti-Tau antibodies and methods of useAC IMMUNE SA·Filed 2019·Granted Jul 14, 2020·7 cites·42 claims
- 0691US10836817B2Anti-Tau antibodies and methods of useAC IMMUNE SA·Filed 2019·Granted Nov 17, 2020·10 cites·22 claims
- 0790US8048420B2Monoclonal antibodyAC IMMUNE SA·Filed 2008·Granted Nov 1, 2011·12 cites·36 claims
- 0887US11684576B2Method of safe administration of phosphorylated tau peptide vaccineAC IMMUNE SA·Filed 2020·Granted Jun 27, 2023·2 cites·20 claims
- 0985US10828351B2Anti-abeta therapeutic vaccinesAC IMMUNE SA·Filed 2019·Granted Nov 10, 2020·3 cites·31 claims
- 1085US7807175B2Therapeutic vaccineAC IMMUNE SA·Filed 2006·Granted Oct 5, 2010·8 cites·45 claims
- 1184US10066010B2Methods of diagnosing diseases caused by or associated with neurofibrillary tangles by phosphospecific antibodies recognising TauAC IMMUNE SA·Filed 2016·Granted Sep 4, 2018·4 cites·14 claims
- 1282US9540434B2Phosphospecific antibodies recognising tauAC IMMUNE SA·Filed 2012·Granted Jan 10, 2017·5 cites·17 claims
- 1381US9657091B2Humanized tau antibodyAC IMMUNE SA·Filed 2013·Granted May 23, 2017·5 cites·22 claims
- 1479US12324855B2Method of safe administration of phosphorylated Tau peptide vaccineAC IMMUNE SA·Filed 2023·Granted Jun 10, 2025·0 cites·20 claims
- 1578US9598485B2Anti-tau antibodies and methods of useAC IMMUNE SA·Filed 2014·Granted Mar 21, 2017·4 cites·66 claims
- 1678US2024350598A1Anti-Abeta Therapeutic VaccinesAC IMMUNE SA·Filed 2024·Application pending·0 cites
- 1777US9975946B2Antibodies obtainable using supramolecular constructsAC IMMUNE SA·Filed 2014·Granted May 22, 2018·2 cites·13 claims
- 1875US9701660B22,6-diaminopyridine compounds suitable for treating diseases associated with amyloid or amyloid-like proteins or for treating or preventing ocular diseases or conditions associated with a pathological abnormality/change in the tissue of the visual systemAC IMMUNE SA·Filed 2014·Granted Jul 11, 2017·2 cites·8 claims
- 1974US2023201320A1Mimotopes of alpha-synuclein and vaccines thereof for the treatment of synucleinopathyAC IMMUNE SA·Filed 2022·Application pending·0 cites
- 2073US11534484B2Mimotopes of alpha-synuclein and vaccines thereof for the treatment of synucleinopathyAC IMMUNE SA·Filed 2019·Granted Dec 27, 2022·0 cites·9 claims
- 2173US2025275920A1Method of Safe Administration of Phosphorylated TAU Peptide VaccineAC IMMUNE SA·Filed 2025·Application pending·0 cites
- 2272US2023043289A1Anti-tau antibodies and methods of useAC IMMUNE SA·Filed 2022·Application pending·0 cites
- 2372US2024051967A1Bicyclic compounds for diagnosis and therapyAC IMMUNE SA·Filed 2023·Application pending·0 cites
- 2470US10633383B2Compounds for the treatment, alleviation or prevention of disorders associated with Tau aggregatesAC IMMUNE SA·Filed 2019·Granted Apr 28, 2020·1 cites·24 claims
- 2569US11427629B2Anti-Tau antibodies and methods of useAC IMMUNE SA·Filed 2020·Granted Aug 30, 2022·0 cites·32 claims
- 2668US2010297132A1Monoclonal antibodyAC IMMUNE SA·Filed 2009·Application pending·0 cites
- 2767US12005102B2Anti-abeta therapeutic vaccinesAC IMMUNE SA·Filed 2020·Granted Jun 11, 2024·0 cites·23 claims
- 2867US10662193B2Carbazole and carboline compounds for use in the diagnosis, treatment, alleviation or prevention of disorders associated with amyloid or amyloid-like proteinsAC IMMUNE SA·Filed 2015·Granted May 26, 2020·1 cites·14 claims
- 2967US10500207B2Compounds for the treatment of diseases associated with amyloid or amyloid-like proteinsAC IMMUNE SA·Filed 2015·Granted Dec 10, 2019·1 cites·18 claims
- 3067US2023255976A1Novel Compounds for the Treatment, Alleviation or Prevention of Disorders Associated with Tau AggregatesAC IMMUNE SA·Filed 2023·Application pending·0 cites
- 3167US2021317197A1Humanized antibodyAC IMMUNE SA·Filed 2020·Application pending·0 cites
- 3267US2024270829A1Vaccine TherapyAC IMMUNE SA·Filed 2023·Application pending·0 cites
- 3366US7807171B2Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancersAC IMMUNE SA·Filed 2004·Granted Oct 5, 2010·4 cites·21 claims
- 3465US2022227847A1Humanized antibodyAC IMMUNE SA·Filed 2021·Application pending·0 cites
- 3564US2020055928A1Humanized antibodyAC IMMUNE SA·Filed 2019·Application pending·0 cites
- 3664US2025152684A1Anti-Alpha-Synuclein Therapeutic VaccinesAC IMMUNE SA·Filed 2023·Application pending·0 cites
- 3763US11352419B2Anti-tau antibodies and methods of useAC IMMUNE SA·Filed 2020·Granted Jun 7, 2022·0 cites·15 claims
- 3863US2026043816A1Anti-TDP-43 Binding MoleculesAC IMMUNE SA·Filed 2023·Application pending·0 cites
- 3962US11684625B2Compounds for the treatment, alleviation or prevention of disorders associated with tau aggregatesAC IMMUNE SA·Filed 2019·Granted Jun 27, 2023·0 cites·12 claims
- 4061US2023340090A1Misfolded TDP-43 Binding MoleculesAC IMMUNE SA·Filed 2022·Application pending·0 cites
- 4161US2024101563A1Novel compoundsAC IMMUNE SA·Filed 2023·Application pending·0 cites
- 4260US2025320284A1Novel Molecules for Therapy and DiagnosisAC IMMUNE SA·Filed 2022·Application pending·0 cites
- 4359US2025042905A1Dihydropyrrolo[3,4-c]pyrazole derivatives and their use in diagnosisAC IMMUNE SA·Filed 2022·Application pending·0 cites
- 4459US2015259406A1Pharmaceutical Composition of an Antigenic Tau Peptide Reconstituted in a Liposome and Related Antibodies and Cell LinesAC IMMUNE SA·Filed 2014·Application pending·0 cites
- 4559US2025034149A1Dihydropyrrolo[3,4c]-pyrazole derivatives and their use in diagnosisAC IMMUNE SA·Filed 2022·Application pending·0 cites
- 4659US2018327485A1Humanized antibodyAC IMMUNE SA·Filed 2017·Application pending·0 cites
- 4759US2024034735A1Novel compoundsAC IMMUNE SA·Filed 2023·Application pending·0 cites
- 4858US11623931B2Bicyclic compounds for diagnosis and therapyAC IMMUNE SA·Filed 2020·Granted Apr 11, 2023·0 cites·10 claims
- 4958US2025018068A14h-imidazo[1,5-b]pyrazole derivatives for diagnosisAC IMMUNE SA·Filed 2022·Application pending·0 cites
- 5056US11814378B2Compounds for the treatment, alleviation or prevention of disorders associated with Tau aggregatesAC IMMUNE SA·Filed 2020·Granted Nov 14, 2023·0 cites·32 claims
Showing the top 50 of 89 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when AC IMMUNE SA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →